Table 5 Characteristics of providers
Treatment | Control | Difference (T-C) | ||
|---|---|---|---|---|
Mean | SE | |||
Female(a) | 0.68 | 0.69 | −0.01 | 0.06 |
Average years of clinical experience | 24.6 | 24.8 | −0.20 | 1.07 |
Average years of clinical experience in family planning | 17.1 | 17.6 | −0.50 | 1.19 |
Providers with dual practice (in public and private sectors) | 0.14 | 0.09 | 0.05 | 0.04 |
Method provision/prescription in clinic | ||||
Copper intrauterine contraceptive device (IUCD) | 0.93 | 0.95 | −0.02 | 0.03 |
Hormonal intrauterine system (Mirena®) | 0.67 | 0.62 | 0.06 | 0.06 |
Implant (Implanon®) | 0.32 | 0.29 | 0.03 | 0.06 |
Combined oral contraceptive (COC) pill | 0.97 | 0.99 | −0.02 | 0.02 |
Progestin-only pill | 0.94 | 0.95 | −0.01 | 0.03 |
Vaginal ring (NuvaRing®) | 0.41 | 0.39 | 0.02 | 0.06 |
Condom | 0.94 | 0.97 | −0.03 | 0.03 |
Female sterilization (e.g. bilateral tubal ligation) | 0.57 | 0.56 | 0.01 | 0.07 |
Male sterilization (vasectomy) | 0.08 | 0.09 | −0.01 | 0.04 |
Baseline Knowledge Score (standardized)(b) | 0.18 | 0.00 | 0.18 | 0.15 |
Baseline Attitude Score (standardized)(b) | 0.15 | 0.00 | 0.15 | 0.15 |
Baseline Practice Score (standardized)(b) | −0.15 | 0.00 | −0.15 | 0.12 |
Baseline Availability of DMPA stock at clinic(b) | 0.20 | 0.24 | −0.03 | 0.06 |
Baseline Average # times discussed DMPA with clients in past month(b) | 5.1 | 5.7 | −0.64 | 1.10 |
Baseline Average # times prescribed DMPA in past month(b) | 2.0 | 2.4 | −0.38 | 0.53 |
N | 117 | 112 | ||